Senior investment professional leading new company creation for Johnson & Johnson Innovation – JJDC, Inc., the strategic venture capital arm of the Johnson & Johnson Family of Companies. Primary responsibility is to fund compelling innovation where we see an opportunity to transform and enhance patient outcomes through the creation of innovative healthcare start-up companies.

Results-driven entrepreneurial business leader offering 20 years’ comprehensive achievements in Start-Up Biotech, Large Pharma & Venture Capital. Significant drug development, operating & business experience and in New Company formation and launch. Deep academic training in the Life Sciences specializing in Clinical Pharmacology with 20 peer reviewed publications, 40 US and 160 foreign issued patents. Kauffman Life Science Fellow (Class 14).